# PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults

> **NCT06863363** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 212 (estimated)

## Conditions studied

- Non-diabetic Obesity

## Interventions

- **DRUG:** PEG-rhGH Injection + Semaglutide Injection
- **DRUG:** Semaglutide Injection

## Key facts

- **NCT ID:** NCT06863363
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06863363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06863363, "PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06863363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*